HiFiBio (HK) Limited
Unit 518, 5/F, Biotech Centre 2,
No. 11 Science Park West Avenue,
Hong Kong Science Park, Pak Shek Kok,
Hong Kong
+86 13816654862
Ms. Rachel Yao
The information provided on this page is for reference only. Please refer to the latest information published by the partner company.
HiFiBiO Therapeutics is a clinical stage biotech company advancing a robust pipeline targeting both the innate and adaptive immunity to treat cancer and autoimmune disease. Our proprietary and versatile DIS™ single-cell platform enables the rapid discovery of novel antibody therapeutics with predictive biomarkers through our internal development programs and strategic collaborations. Our passionate team across three continents embraces a fast-paced and engaging work environment to bring transformative medicines to patients.
For more information, please visit www.hifibio.com